Good news: on the 2nd June, the PedMAb 1 trial had recruited a total of 24 baby participants.
This means that the recruitment for 3 of the 9 arms in the trial is complete!
Very encouraging!
A pediatric phase I/II trial to determine safety and pharmacokinetics of broadly neutralizing monoclonal antibodies against HIV-1